Phibro Animal Health
PAHC
$12.87
Share price
-0.92%
Change (1 day)
-18.90%
Change (1 year)
Revenue for Phibro Animal Health (PAHC)
Revenue in 2023 (TTM): $0.98 B
According to Phibro Animal Health 's latest financial reports the company's current revenue (TTM) is $0.98 B. In 2022 the company made a revenue of $0.97 B an increase over the years 2021 revenue that were of $0.87 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Phibro Animal Health from 2013 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.98 B | 1.02% |
| 2022 | $0.97 B | 10.54% |
| 2021 | $0.87 B | 10.2% |
| 2020 | $0.79 B | -1.89% |
| 2019 | $0.81 B | -3.07% |
| 2018 | $0.83 B | 7.03% |
| 2017 | $0.78 B | 4.22% |
| 2016 | $0.75 B | 0.12% |
| 2015 | $0.75 B | 2.49% |
| 2014 | $0.73 B | 10.76% |
| 2013 | $0.66 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $34.12 B | 3,374.91% | 🇺🇸 USA |
 Archer Daniels Midland (ADM)
ADM | $93.93 B | 9,465.55% | 🇺🇸 USA |
 Zoetis ZTS | $8.54 B | 770.05% | 🇺🇸 USA |
 Merck MRK | $60.11 B | 6,021.50% | 🇺🇸 USA |
 Kindred Biosciences
KIN | $7.92 M | -99.19% | 🇺🇸 USA |
 Heska Corporation
HSKA | $0.25 B | -74.04% | 🇺🇸 USA |